Addiction & Alcoholism

Two Hits for Schizophrenia

After over a century of failing to find a causal link between cannabis use and schizophrenia, proponents of Reefer Madness have had to couch their warnings.

Enough to Drink?

donuts!

Researchers have modulated cannabinoid CB1 receptors in addiction treatment in order to affect cravings, the formation of habits, one’s sensitivity to triggers, withdrawal symptoms, and the pleasure one derives from drug use. Now scientists at the National Institute on Alcohol Abuse and Alcoholism have added a new factor to the list: feeling satiated. As the paper published in Cell Metabolism describes, suppressing CB1 activity outside of the central nervous system reduces mice’s desire to drink.

Thanks to our sponsors and supporters:

Top Stories